Orexin receptor antagonists: a new concept in CNS disorders?

ChemMedChem. 2010 Aug 2;5(8):1197-214. doi: 10.1002/cmdc.201000132.
No abstract available

Publication types

  • Review

MeSH terms

  • Acetamides / chemistry
  • Acetamides / therapeutic use
  • Azepines / chemistry
  • Azepines / therapeutic use
  • Central Nervous System Diseases / drug therapy*
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Intracellular Signaling Peptides and Proteins / physiology
  • Isoquinolines / chemistry
  • Isoquinolines / therapeutic use
  • Neuropeptides / metabolism
  • Neuropeptides / physiology
  • Orexin Receptors
  • Orexins
  • Patents as Topic
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Neuropeptide / antagonists & inhibitors*
  • Receptors, Neuropeptide / metabolism
  • Signal Transduction
  • Triazoles / chemistry
  • Triazoles / therapeutic use

Substances

  • Acetamides
  • Azepines
  • Intracellular Signaling Peptides and Proteins
  • Isoquinolines
  • Neuropeptides
  • Orexin Receptors
  • Orexins
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Triazoles
  • suvorexant
  • almorexant